Enzo Biochem (ENZ)
0.6360 -0.0171 (-2.62%) 11:14 ET [NYSE]
0.6356 x 100 0.6425 x 100
Realtime by (Cboe BZX)
0.6356 x 100 0.6425 x 100
Realtime 0.6344 -0.0187 (-) 09:26 ET
for Mon, Jan 27th, 2025
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 52,371 | 57,156 | 60,241 | 69,207 | 82,373 |
Receivables | 3,988 | 3,935 | 5,116 | 4,181 | 4,808 |
Inventories | 6,832 | 7,324 | 7,800 | 7,595 | 7,939 |
Other current assets | 5,000 | 0 | 0 | 0 | 0 |
TOTAL | $70,031 | $75,736 | $80,920 | $88,012 | $98,456 |
Non-Current Assets | |||||
PPE Net | 12,367 | 12,638 | 12,837 | 13,075 | 13,086 |
Other Non-Current Assets | 3,366 | 5,095 | 5,320 | 5,221 | 10,338 |
TOTAL | $15,733 | $17,733 | $18,157 | $18,296 | $23,424 |
Total Assets | $85,764 | $93,469 | $99,077 | $106,308 | $121,880 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | 75 | N/A | N/A | N/A |
Accounts payable and accrued liabilities | 1,376 | 1,520 | 1,318 | 1,962 | 3,575 |
Accrued Expenses | 5,714 | 5,376 | 7,526 | 10,042 | 11,743 |
Other current liabilities | 76 | N/A | 75 | 75 | 75 |
TOTAL | $24,794 | $21,663 | $25,283 | $28,842 | $39,989 |
Non-Current Liabilities | |||||
Long Term Debt | 189 | 180 | 234 | 219 | 269 |
aiOther Non-Current Liabilities | 4,669 | 2,595 | 2,785 | 2,972 | 3,160 |
TOTAL | $4,858 | $2,775 | $3,019 | $3,191 | $3,429 |
Total Liabilities | $29,652 | $24,438 | $28,302 | $32,033 | $43,418 |
Shareholders' Equity | |||||
Shares Outstanding, K | 52,244 | 51,458 | 51,226 | 50,490 | 50,490 |
Common Shares | 521 | 511 | 504 | 504 | 499 |
Retained earnings | -294,428 | -281,047 | -278,027 | -274,966 | -268,350 |
Other shareholders' equity | 1,885 | 2,498 | 2,046 | 2,746 | 1,878 |
TOTAL | $56,112 | $69,031 | $70,775 | $74,275 | $78,462 |
Total Liabilities And Equity | $85,764 | $93,469 | $99,077 | $106,308 | $121,880 |